Original Research
Published on 25 Jan 2024
Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1354950
- 20,015 views
- 22 citations

